Clinical Trials Directory

Trials / Completed

CompletedNCT04065893

Impact of Catheter Ablation of Ventricular Arrhythmias on Suboptimal Biventricular Pacing in Cardiac Resynchronization Therapy

Status
Completed
Phase
Study type
Observational
Enrollment
65 (actual)
Sponsor
Universitätsklinikum Köln · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Cardiac resynchronization therapy reduces mortality in patients with systolic heart failure and left bundle branch block. Reduced biventricular pacing can lead to therapy failure. Most effective mortality reduction was seen with a BiV pacing above 98%. Reduced BiV pacing is a common phenomenon with potential impact on CRT-response and pts' prognosis. Frequent ventricular ectopy may be associated with attenuated benefit from CRT. The investigators sought to systematically assess the effect of ventricular arrhythmia treatment on BiV pacing.

Conditions

Interventions

TypeNameDescription
PROCEDURECatheter ablation of ventricular arrhythmiaPVC or VT ablation
DRUGIntensified medical therapyDosage increase / new onset of Betablocker / medical antiarrhythmic medication according to guideline and clinical practice

Timeline

Start date
2020-09-01
Primary completion
2021-08-01
Completion
2021-08-01
First posted
2019-08-22
Last updated
2021-11-15

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT04065893. Inclusion in this directory is not an endorsement.